Prudential Financial Inc Ionis Pharmaceuticals Inc Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 90,017 shares of IONS stock, worth $3.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,017

Previous 15,717 472.74%

Holding current value

$3.06 Million

Previous $749,000 381.44%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.06 - $51.86 $2.98 Million - $3.85 Million	74,300 Added 472.74%	90,017 $3.61 Million
Q2 2024 Aug 13, 2024	BUY	$36.45 - $47.7 $572,884 - $749,700	15,717 New	15,717 $749,000
Q4 2023 Feb 13, 2024	BUY	$43.39 - $51.63 $185,231 - $220,408	4,269 New	4,269 $215,000
Q3 2022 Nov 04, 2022	BUY	$36.54 - $48.66 $186,280 - $248,068	5,098 New	5,098 $226,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $147,590 - $202,281	-5,763 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $20,492 - $24,776	611 Added 11.86%	5,763 $214,000
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $150,801 - $206,293	-4,366 Reduced 45.87%	5,152 $205,000
Q1 2021 May 12, 2021	SELL	$42.51 - $63.78 $1.53 Million - $2.3 Million	-36,009 Reduced 79.09%	9,518 $428,000
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $2.02 Million - $2.68 Million	44,523 Added 4434.56%	45,527 $2.57 Million
Q3 2020 Aug 05, 2021	SELL	$47.45 - $62.95 $2.38 Million - $3.16 Million	-50,227 Reduced 98.04%	1,004 $48,000
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $2.38 Million - $3.16 Million	50,188 Added 4811.89%	51,231 $2.43 Million
Q2 2020 Aug 05, 2021	SELL	$46.85 - $61.05 $2.04 Million - $2.66 Million	-43,538 Reduced 97.66%	1,043 $61,000
Q2 2020 Aug 12, 2020	BUY	$46.85 - $61.05 $2.08 Million - $2.71 Million	44,461 Added 37050.83%	44,581 $2.63 Million
Q1 2020 Aug 05, 2021	SELL	$41.6 - $63.4 $307,049 - $467,955	-7,381 Reduced 98.4%	120 $6,000
Q1 2020 May 12, 2020	BUY	$41.6 - $63.4 $307,257 - $468,272	7,386 Added 6422.61%	7,501 $354,000
Q4 2019 Aug 05, 2021	SELL	$53.85 - $65.27 $292,728 - $354,807	-5,436 Reduced 97.93%	115 $7,000
Q4 2019 Feb 11, 2020	BUY	$53.85 - $65.27 $292,190 - $354,155	5,426 Added 4340.8%	5,551 $335,000
Q3 2019 Aug 05, 2021	SELL	$59.06 - $72.15 $914,012 - $1.12 Million	-15,476 Reduced 99.2%	125 $7,000
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $914,012 - $1.12 Million	15,476 Added 12380.8%	15,601 $934,000
Q2 2019 Aug 05, 2021	SELL	$62.09 - $86.14 $1.09 Million - $1.51 Million	-17,576 Reduced 99.29%	125 $8,000
Q2 2019 Aug 08, 2019	BUY	$62.09 - $86.14 $1.09 Million - $1.52 Million	17,606 Added 18532.63%	17,701 $0
Q1 2019 Aug 05, 2021	SELL	$52.92 - $81.17 $949,702 - $1.46 Million	-17,946 Reduced 99.47%	95 $8,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $946,580 - $1.45 Million	17,887 Added 11614.94%	18,041 $0
Q4 2018 Aug 05, 2021	SELL	$43.37 - $59.54 $363,744 - $499,361	-8,387 Reduced 98.2%	154 $8,000
Q4 2018 Feb 07, 2019	BUY	$43.37 - $59.54 $367,951 - $505,137	8,484 Added 14884.21%	8,541 $461,000
Q3 2018 Sep 01, 2021	SELL	$42.88 - $53.7 $372,369 - $466,330	-8,684 Reduced 99.35%	57 $3,000
Q3 2018 Nov 07, 2018	BUY	$42.88 - $53.7 $17,152 - $21,480	400 Added 4.8%	8,741 $0
Q2 2018 Aug 13, 2018	BUY	$40.53 - $50.7 $77,007 - $96,330	1,900 Added 29.5%	8,341 $0
Q4 2017 Feb 13, 2018	SELL	$50.3 - $64.39 $140,840 - $180,292	-2,800 Reduced 30.3%	6,441 $324,000
Q3 2017 Nov 02, 2017	BUY	$45.56 - $59.57 $421,019 - $550,486	9,241	9,241 $469,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Ionis Pharmaceuticals Inc Transaction History